{"id":"https://openalex.org/W2603147667","doi":"https://doi.org/10.1111/ijlh.12647","title":"Lack of rivaroxaban influence on a prothrombinase\u2010based assay for the detection of activated C protein resistance: an Italian ex vivo and in vitro study in normal subjects and factor V Leiden carriers","display_name":"Lack of rivaroxaban influence on a prothrombinase\u2010based assay for the detection of activated C protein resistance: an Italian ex vivo and in vitro study in normal subjects and factor V Leiden carriers","publication_year":2017,"publication_date":"2017-03-20","ids":{"openalex":"https://openalex.org/W2603147667","doi":"https://doi.org/10.1111/ijlh.12647","mag":"2603147667","pmid":"https://pubmed.ncbi.nlm.nih.gov/28318106"},"language":"en","primary_location":{"id":"doi:10.1111/ijlh.12647","doi":"https://doi.org/10.1111/ijlh.12647","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ijlh.12647","pdf_url":null,"source":{"id":"https://openalex.org/S66208518","display_name":"International Journal of Laboratory Hematology","issn_l":"1751-5521","issn":["1751-5521","1751-553X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Laboratory Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114911262","display_name":"Gianluca Gessoni","orcid":"https://orcid.org/0000-0003-3639-3486","observed_orcids":["https://orcid.org/0000-0003-3639-3486","https://orcid.org/0000-0002-9272-4211"]},"institutions":[{"id":"https://openalex.org/I4210144715","display_name":"Ospedale dell' Angelo","ror":"https://ror.org/040d6j646","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210144715"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"G. Gessoni","raw_affiliation_strings":["Trasfusional Deptartment of Venetian District, Ospedale dell'Angelo, Mestre, Venice, Italy"],"raw_orcid":"https://orcid.org/0000-0002-9272-4211","affiliations":[{"raw_affiliation_string":"Trasfusional Deptartment of Venetian District, Ospedale dell'Angelo, Mestre, Venice, Italy","institution_ids":["https://openalex.org/I4210144715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108853102","display_name":"S. Valverde","orcid":"https://orcid.org/0000-0001-9790-7458","observed_orcids":["https://orcid.org/0000-0001-9790-7458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Valverde","raw_affiliation_strings":["Laboratory Medicine, Ospedale Madonna della Navicella, Chioggia, Venice, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, Ospedale Madonna della Navicella, Chioggia, Venice, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083881331","display_name":"Letizia Valle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Valle","raw_affiliation_strings":["Cardiology and Intensive Coronary Unit, Ospedale Madonna della Navicella, Chioggia, Venice, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology and Intensive Coronary Unit, Ospedale Madonna della Navicella, Chioggia, Venice, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007906156","display_name":"Francesca Gessoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Gessoni","raw_affiliation_strings":["Laboratory Medicine, Ospedale Madonna della Navicella, Chioggia, Venice, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, Ospedale Madonna della Navicella, Chioggia, Venice, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111881417","display_name":"Pierpaolo Caruso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Caruso","raw_affiliation_strings":["DASIT SpA, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DASIT SpA, Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"R. Valle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Valle","raw_affiliation_strings":["Cardiology and Intensive Coronary Unit, Ospedale Madonna della Navicella, Chioggia, Venice, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology and Intensive Coronary Unit, Ospedale Madonna della Navicella, Chioggia, Venice, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5114911262"],"corresponding_institution_ids":["https://openalex.org/I4210144715"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.6196,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.69236368,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"39","issue":"4","first_page":"418","last_page":"422"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/activated-protein-c-resistance","display_name":"activated protein C resistance","score":0.8889999985694885},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.949999988079071},{"id":"https://openalex.org/keywords/factor-v-leiden","display_name":"factor V Leiden","score":0.8769999742507935},{"id":"https://openalex.org/keywords/direct-factor-xa-inhibitors","display_name":"direct factor Xa inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/assay-interference","display_name":"assay interference","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hypercoagulability","display_name":"hypercoagulability","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C112516734","wikidata":"https://www.wikidata.org/wiki/Q423640","display_name":"Prothrombinase","level":4,"score":0.9121138453483582},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8674213290214539},{"id":"https://openalex.org/C2779956388","wikidata":"https://www.wikidata.org/wiki/Q296104","display_name":"Activated protein C resistance","level":5,"score":0.7516372799873352},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.6881403923034668},{"id":"https://openalex.org/C2777175894","wikidata":"https://www.wikidata.org/wiki/Q185986","display_name":"Factor V Leiden","level":4,"score":0.6102479696273804},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5594839453697205},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5480681657791138},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47594738006591797},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47019895911216736},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3143117427825928},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.2963630259037018},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2854349911212921},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2586515545845032},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20091143250465393},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1929137110710144},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.16381791234016418},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.10674884915351868},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.08217164874076843},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.05146476626396179},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005165","descriptor_name":"Factor V","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005166","descriptor_name":"Factor V Deficiency","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005166","descriptor_name":"Factor V Deficiency","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005166","descriptor_name":"Factor V Deficiency","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005166","descriptor_name":"Factor V Deficiency","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006720","descriptor_name":"Homozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013925","descriptor_name":"Thromboplastin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020016","descriptor_name":"Activated Protein C Resistance","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/ijlh.12647","doi":"https://doi.org/10.1111/ijlh.12647","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ijlh.12647","pdf_url":null,"source":{"id":"https://openalex.org/S66208518","display_name":"International Journal of Laboratory Hematology","issn_l":"1751-5521","issn":["1751-5521","1751-553X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Laboratory Hematology","raw_type":"journal-article"},{"id":"pmid:28318106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28318106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of laboratory hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W458440","https://openalex.org/W93260398","https://openalex.org/W1510534303","https://openalex.org/W1884897052","https://openalex.org/W1966076933","https://openalex.org/W1994219619","https://openalex.org/W2008451429","https://openalex.org/W2014616799","https://openalex.org/W2016754244","https://openalex.org/W2019960723","https://openalex.org/W2040812969","https://openalex.org/W2072034382","https://openalex.org/W2078046705","https://openalex.org/W2084969719","https://openalex.org/W2087332309","https://openalex.org/W2105644555","https://openalex.org/W2126989192","https://openalex.org/W2128811936","https://openalex.org/W2132953336","https://openalex.org/W2163853479","https://openalex.org/W2467227824","https://openalex.org/W2519995538"],"related_works":["https://openalex.org/W93260398","https://openalex.org/W1966076933","https://openalex.org/W1510534303","https://openalex.org/W2755106144","https://openalex.org/W2519995538","https://openalex.org/W3007626216","https://openalex.org/W7097991292","https://openalex.org/W2982099586","https://openalex.org/W2134665360","https://openalex.org/W2979694967"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Activated":[1],"protein":[2],"C":[3],"resistance":[4],"(APCr)":[5],"leads":[6],"to":[7,16,27,143,185,195,211],"hypercoagulability":[8],"and":[9,32,69,95,115,149,153,162,181],"is":[10],"due,":[11],"often":[12],"but":[13],"not":[14,168],"exclusively,":[15],"Factor":[17],"V":[18],"Leiden":[19],"(FVL).":[20],"The":[21],"aim":[22],"of":[23,36,127,179,188,207],"this":[24,182],"study":[25,55,81],"was":[26,56,82,109,117,137,183],"assess":[28],"the":[29,37,172,177,205],"ex":[30,53,160],"vivo":[31,54,161],"in":[33,79,146,163,204],"vitro":[34,80],"interference":[35,126],"direct":[38],"factor":[39],"Xa":[40],"inhibitor":[41],"rivaroxaban":[42],"(RIV)":[43],"on":[44,58,84,129],"a":[45,112,120,134],"prothrombinase-based":[46,121,135,173],"assay":[47,136,174],"for":[48,139,176],"APCr":[49,116,130],"detection.":[50],"METHODS:":[51],"An":[52,78],"performed":[57,83],"fresh":[59],"plasma":[60,86],"samples":[61,87],"obtained":[62,132],"from":[63,89,93,97],"44":[64],"subjects":[65],"with":[66,71,76,105,171],"FV":[67,147,189],"wild-type":[68,148],"seven":[70],"FVL":[72,99,150],"heterozygous,":[73,94],"all":[74,101],"treated":[75],"RIV.":[77,106],"15":[85],"(six":[88],"normal":[90],"subjects,":[91],"six":[92],"three":[96],"homozygous":[98],"carriers,":[100],"frozen":[102],"specimens)":[103],"spiked":[104],"RIV":[107,128,166],"concentration":[108],"evaluated":[110,118],"using":[111],"chromogenic":[113],"assay,":[114],"by":[119,133],"assay.":[122],"RESULTS:":[123],"No":[124],"significant":[125],"results":[131,156],"observed":[138,184],"drug":[140],"concentrations":[141,193],"up":[142,194],"400":[144,196],"ng/mL":[145,197],"carriers":[151],"(homozygous":[152],"heterozygous).":[154],"These":[155],"were":[157,198],"confirmed":[158],"both":[159],"vitro.":[164],"CONCLUSIONS:":[165],"did":[167],"significantly":[169],"interfere":[170],"used":[175],"assessment":[178],"APCr,":[180],"occur":[186],"independently":[187],"status.":[190],"However,":[191],"only":[192],"tested":[199],"and,":[200],"therefore,":[201],"what":[202],"occurs":[203],"presence":[206],"higher":[208],"doses":[209],"remains":[210],"be":[212],"investigated.":[213]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}